The MAP kinase inhibitor PD98059 reduces chromosomal instability in the autoimmune encephalomyelitis SJL/J-mouse model of multiple sclerosis-Reference-Cited by-同舟云学术

The MAP kinase inhibitor PD98059 reduces chromosomal instability in the autoimmune encephalomyelitis SJL/J-mouse model of multiple sclerosis

Published:2021-01 Issue: Volume:861-862 Page:503278
ISSN:1383-5718
Container-title:Mutation Research/Genetic Toxicology and Environmental Mutagenesis
language:en
Short-container-title:Mutation Research/Genetic Toxicology and Environmental Mutagenesis

Author:

Attia Sabry M.,Ahmad Sheikh F.,Nadeem Ahmed,Attia Mohamed S.M.,Ansari Mushtaq A.,Harisa Gamaleldin I.,Al-Hamamah Mohammed A.,Mahmoud Mohamed A.,Bakheet Saleh A.

Funder

King Saud University

Publisher

Elsevier BV

Subject

Health, Toxicology and Mutagenesis,Genetics

Reference66 articles.

1. Multiple sclerosis;Noseworthy;N Engl J Med,2000

2. Sex and gender issues in multiple sclerosis;Harbo;Ther Adv Neurol Disord,2013

3. Editorial: Multiple sclerosis: pathogenesis and therapeutics;Katsara;Med Chem,2018

4. Relapsing and progressive forms of multiple sclerosis: insights from pathology;Dutta;Curr Opin Neurol,2014

5. Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis;Olsson;Nat Rev Neurol,2017

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dabrafenib mitigates the neuroinflammation caused by ferroptosis in experimental autoimmune encephalomyelitis by up regulating Axl receptor;European Journal of Pharmacology;2024-06

2. MAP kinase inhibitor PD98059 regulates Th1, Th9, Th17, and natural T regulatory cells in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis;European Journal of Pharmacology;2023-11

3. Mitogen-activated protein kinase inhibitor PD98059 improves neuroimmune dysfunction in experimental autoimmune encephalomyelitis in SJL/J mice through the inhibition of nuclear factor-kappa B signaling in B cells;Brain Research Bulletin;2023-03

4. Semaglutide, a novel glucagon-like peptide-1 agonist, amends experimental autoimmune encephalomyelitis-induced multiple sclerosis in mice: Involvement of the PI3K/Akt/GSK-3β pathway;International Immunopharmacology;2023-02

5. High-density lipoprotein reduces microglia activation and protects against experimental autoimmune encephalomyelitis in mice;International Immunopharmacology;2022-04